Legal & General Group PLC Incyte Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Incyte Corp stock. As of the latest transaction made, Legal & General Group PLC holds 1,742,027 shares of INCY stock, worth $125 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,742,027
Previous 1,742,027 -0.0%
Holding current value
$125 Million
Previous $115 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$57.33 - $68.61 $7.23 Million - $8.65 Million
-126,103 Reduced 6.75%
1,742,027 $115 Million
Q2 2024

Aug 14, 2024
SELL
$51.18 - $63.75 $4.13 Million - $5.15 Million
-80,766 Reduced 4.14%
1,868,130 $113 Million
Q1 2024

May 14, 2024
SELL
$56.55 - $66.59 $398,847 - $469,659
-7,053 Reduced 0.36%
1,948,896 $111 Million
Q4 2023

Feb 15, 2024
BUY
$52.16 - $64.19 $11.4 Million - $14.1 Million
219,025 Added 12.61%
1,955,949 $123 Million
Q3 2023

Nov 14, 2023
SELL
$57.77 - $65.93 $3.05 Million - $3.48 Million
-52,799 Reduced 2.95%
1,736,924 $100 Million
Q2 2023

Aug 14, 2023
BUY
$60.95 - $75.51 $14.5 Million - $18 Million
238,045 Added 15.34%
1,789,723 $111 Million
Q1 2023

May 15, 2023
BUY
$70.23 - $86.01 $2.7 Million - $3.31 Million
38,474 Added 2.54%
1,551,678 $112 Million
Q4 2022

Feb 14, 2023
BUY
$67.18 - $84.11 $2.13 Million - $2.67 Million
31,723 Added 2.14%
1,513,204 $122 Million
Q3 2022

Nov 14, 2022
SELL
$66.18 - $82.86 $579,405 - $725,439
-8,755 Reduced 0.59%
1,481,481 $98.7 Million
Q2 2022

Aug 22, 2022
BUY
$66.18 - $83.18 $7.88 Million - $9.9 Million
119,041 Added 8.68%
1,490,236 $113 Million
Q1 2022

May 16, 2022
BUY
$66.02 - $79.71 $7.14 Million - $8.63 Million
108,212 Added 8.57%
1,371,195 $109 Million
Q4 2021

Feb 14, 2022
SELL
$63.34 - $74.11 $3.73 Million - $4.37 Million
-58,957 Reduced 4.46%
1,262,983 $92.7 Million
Q3 2021

Nov 15, 2021
BUY
$68.67 - $84.02 $3.58 Million - $4.38 Million
52,100 Added 4.1%
1,321,940 $90.9 Million
Q2 2021

Aug 12, 2021
BUY
$79.87 - $87.53 $4.8 Million - $5.26 Million
60,053 Added 4.96%
1,269,840 $107 Million
Q1 2021

May 17, 2021
BUY
$76.02 - $100.5 $744,235 - $983,895
9,790 Added 0.82%
1,209,787 $98.3 Million
Q4 2020

Feb 12, 2021
BUY
$80.74 - $97.7 $3.69 Million - $4.47 Million
45,718 Added 3.96%
1,199,997 $104 Million
Q3 2020

Nov 13, 2020
SELL
$85.07 - $109.69 $1.16 Million - $1.5 Million
-13,693 Reduced 1.17%
1,154,279 $104 Million
Q2 2020

Aug 14, 2020
BUY
$74.18 - $108.93 $3.01 Million - $4.42 Million
40,564 Added 3.6%
1,167,972 $121 Million
Q1 2020

May 14, 2020
BUY
$63.18 - $85.97 $2.36 Million - $3.21 Million
37,368 Added 3.43%
1,127,408 $82.6 Million
Q4 2019

Feb 13, 2020
BUY
$73.04 - $95.72 $3.15 Million - $4.12 Million
43,086 Added 4.12%
1,090,040 $95.2 Million
Q3 2019

Nov 13, 2019
BUY
$72.82 - $86.52 $824,759 - $979,925
11,326 Added 1.09%
1,046,954 $77.7 Million
Q2 2019

Aug 14, 2019
BUY
$73.52 - $88.7 $351,058 - $423,542
4,775 Added 0.46%
1,035,628 $88 Million
Q1 2019

May 15, 2019
BUY
$63.56 - $88.17 $13.3 Million - $18.5 Million
209,813 Added 25.55%
1,030,853 $88.7 Million
Q4 2018

Feb 15, 2019
BUY
$58.5 - $69.94 $2.55 Million - $3.05 Million
43,602 Added 5.61%
821,040 $52.2 Million
Q3 2018

Nov 20, 2018
BUY
$61.75 - $74.23 $1.55 Million - $1.87 Million
25,136 Added 3.34%
777,438 $53.7 Million
Q2 2018

Aug 10, 2018
SELL
$60.85 - $83.98 $1.49 Million - $2.05 Million
-24,426 Reduced 3.14%
752,302 $50.4 Million
Q1 2018

May 17, 2018
SELL
$83.06 - $100.98 $17.3 Million - $21 Million
-208,239 Reduced 21.14%
776,728 $64.7 Million
Q4 2017

Feb 13, 2018
BUY
$93.56 - $116.6 $92.2 Million - $115 Million
984,967
984,967 $93.3 Million

Others Institutions Holding INCY

# of Institutions
649
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email